Accelerating Rare disease Cures (ARC) Program Emerges as a Conduit for Empowering Rare Disease Stakeholders

The ARC Program strives to increase the number of treatments by promoting innovative scientific design, providing a deeper understanding of regulatory policies, and engaging with patients and their advocates, and other rare disease stakeholders.

Source: FDA Center for Drug Evaluation and Research - What's New - June 13, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news